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1. Introduction 
1.1 Synovitis and the chicken or the egg dilemma 
The studies approaching pathogenesis of rheumatoid arthritis shifted over the years to show 
that non-immune factors could precede activation of immune cells and were therefore 
targetable (Firestein & Zvaifler, 1990). In opposition to the classic model, in which an initial 
challenge to the immune system would over time lead to the autoimmune attack of joints, it 
was suggested that early mechanisms of disease induction were to be found inside joints. It 
was observed in vitro, that cells from the joints of patients with rheumatoid arthritis 
spontaneously produced several cytokines (Brennan et al., 1989a). Further studies would 
confirm the role of tumour necrosis factor alpha (TNF) as a master cytokine, since its 
inhibition led to a drop in levels of the other soluble mediators (Brennan et al., 1989b), as 
well as reduction in the expression of HLA-DR molecules (Haworth et al., 1991). 
Interestingly, TNF was not lymphocyte restricted, but rather pleiotropic. Moreover, it was 
shown that its principal sources in the arthritic joint were resident macrophages and 
fibroblast-like cells. This new paradigm was followed by the successful introduction of anti-
cytokine therapies, which have totally changed the clinical picture of RA. 
Indeed, the rheumatoid lesion at joints is quite unique, and probably sufficient to define the 
disease. It is characterized by the development of synovitis, a tumour-like transformation of 
the synovial tissue (Arend, 1997). On one hand, synovitis leads to joint destruction and 
disability, and on the other it provides a stronghold for spreading the inflammatory process. 
1.2 Role of synovial fibroblasts in synovitis 
1.2.1 Invasive features of synovial fibroblasts 
There is not a uniform theory to explain how synovitis develops. However, one of the major 
features of synovitis is the acquisition of invasiveness of synovial fibroblasts. It could be said 
that rheumatoid synovial fibroblasts exhibit features of transformed cells, but unlike these, 
they do not show genetic aberrations. Rather, it seems that different activation processes are 
not correctly balanced by regulatory mechanisms in these cells. In this regard, it is typical of 
rheumatoid synovial fibroblasts to constitutively express growth factors, adhesion 
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molecules and proteases, which participate in inflammation and in the destruction of joint 
tissues (Pap et al., 2005).  
One particularly altered regulatory mechanism in rheumatoid synovial fibroblasts is cell 
growth. In healthy individuals, the synovial membrane is formed by a limiting row of cells, 
the synovial intima, which overlays connective tissue in an epithelium-like fashion. In 
rheumatoid arthritis, the intimal layer is characteristically disarranged and hyperplastic 
(Tarner et al., 2005). Along with the infiltration by leukocytes, there is an increase in the 
density of synovial fibroblasts. However, the latter does not derive from a high proliferation 
rate, but from cell longevity. These cells are able to survive in adverse conditions, such as 
hypoxia and loss of matrix anchorage. Defective apoptosis might therefore be a critical 
process in acquisition of invasiveness, and different works have shed light on this, 
describing specific alterations in the regulation of death mechanisms in rheumatoid arthritis 
(Takami et al., 2003; Jüngel et al., 2006). But on the whole it could be said that the apoptotic 
machinery of rheumatoid synovial fibroblasts is not impaired, and most of its deregulation 
could be due to the influence of signals from the inflamed environment (Kammouni et al., 
2007).  
How rheumatoid synovial cells become invasive brings back the chicken or the egg 
dilemma. Are they mere effectors activated by immune cells or is it the activation of these 
cells by innate mechanisms what helps to trespass the barrier of peripheral tolerance, at the 
same time conferring them with aggressive features? Increasing evidence is rising 
supporting that local factors associated to inflammation can shape the phenotype of 
rheumatoid synovial fibroblasts. An intriguing feature of rheumatoid synovitis is local 
hypoxia (Stevens et al., 1991). The formation of new vessels is characteristic of synovitis, but 
still the density of blood vessels is insufficient to supply the overgrown tissue, so 
consequently there are focal areas of ischemia inside the inflamed joint. It has been shown 
that reduced oxygen leads to an activation of hypoxia sensitive elements, orchestrated by 
hypoxia induced transcription factor-1 (HIF-1). Apparently, there is a low threshold for the 
induction of the hypoxia program in rheumatoid arthritis, probably resulting from the 
stabilisation of HIF-1 by inflammatory cytokines. The vascular endothelium growth factor 
(VEGF) is one of the molecules induced by HIF-1 thought to play a prominent role in the 
acquisition of invasiveness by rheumatoid synovial fibroblasts (Distler et al., 2004). 
1.2.2 Hurdles in the study of rheumatoid synovial fibroblasts’ features 
Synovitis is a non-conventional lesion, and it is difficult to put it into experimental 
coordinates in order to dissect its pathogenic mechanisms. Nonetheless, in primary cultures, 
rheumatoid synovial fibroblasts but not synovial fibroblasts from osteoarthritic or healthy 
joints, are able to maintain an activated phenotype after several passages. This rare feature 
suggests that cells carry with them a stable imprinting of the in vivo circumstances. 
However, in vitro studies have frequently failed to identify or consistently replicate 
mechanisms associated to acquisition of invasiveness by rheumatoid synovial fibroblasts. A 
possible explanation is that cells from the same joint can exhibit a heterogeneous spectrum 
of phenotypes (Kasperkovitz et al., 2005). In large synovial specimens, an alternation can be 
observed between overgrown sprouts of tissue (macroscopic villi) and normal-appearing 
areas, a finding that suggests that the aggressive transformation of synovial fibroblasts is 
focal. Studies based on primary cultures, as well as on high throughput techniques, can miss 
the features of small but critical subpopulations of cells. 
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In order to overcome these limitations, elegant strategies have been employed for the study 
of invasiveness of rheumatoid synovial fibroblasts. An interesting approach is to specifically 
look at areas where synovium invades cartilage and bone, the so-called cartilage-pannus 
junction (CPJ), looking for selective expression of molecules conferring invasiveness (Benito 
et al., 2004). From this type of study we have learned that cells located in the invasive fronts 
are mostly macrophages and fibroblasts. Both the up-regulation of anti-apoptotic factors, 
such as sentrin 1 and the Fas associated death domain-like interleukin 1 converting enzyme 
inhibitory protein (FLIP), and the expression of protooncogenes, have been found in these 
areas (Franz et al., 2000; Schedel et al., 2002). On the other hand, studies looking into CPJs 
are necessarily carried out in specimens obtained at the time of joint replacement surgery. 
Therefore, we need to be cautious at drawing conclusions, because these samples could 
reflect longstanding instead of active disease. 
The invasive process has been studied in vitro in a transwell system with Matrigel, a 
method that was designed for the study of metastasis (Tolboom et al., 2002). More recently, 
a matrix-associated transepithelial resistance invasion (MATRIN) assay was developed to 
measure the rate of invasiveness from the breakdown of the electrical resistance generated 
by an epithelial monolayer (Wunrau et al., 2009). This system provides a means of directly 
assessing the participation of a particular factor in the ability of cells to scatter through the 
matrix. Also interesting are several three-dimensional co-culture systems in which minced, 
artificially generated, or native cartilage is put into contact with different subsets of cells that 
are present at the CPJ. 
The experimental severe cellular immunodeficient (SCID) mouse co-implantation model 
allows the study of mechanisms of invasion in vivo. In this model, human cartilage and 
rheumatoid synovial fibroblasts are engrafted in nude mice, that is, in an immune 
independent environment. Several works using this model have shown the ability of 
rheumatoid synovial fibroblasts to migrate and to destroy cartilage in the absence of 
immune cell concurrence (Müller-Ladner et al., 1996). On the other hand, some mechanisms 
of destruction taking place in rheumatoid arthritis might not show up in the SCID mouse 
model, as the latter does not provide an inflammatory microenvironment comparable to 
synovitis (Jüngel et al, 2010). 
1.2.3 The family of metalloproteinases and related molecules 
There are probably several mechanisms accounting for cartilage and bone destruction in 
rheumatoid arthritis, and different cells and mediators can be involved. Activation of 
osteoclasts through the RANK ligand system stands as the principal pathway of bone 
erosion. In this sense, synovial fibroblasts, among other cell types, have an undeniable role 
as inductors of osteoclast differentiation and maturation in arthritic joints (Kim et al., 2007). 
But there is also much evidence of the direct ability of synovial fibroblasts to penetrate the 
adjacent joint structures as a result of their production of various proteases.  
Metalloproteinases (MMPs) are a family of Zn2+ binding endoproteinases able to degrade 
the connective tissue. They are synthesized as precursors and cleaved at the N-terminus to 
their active forms. There is a considerable overlap of functions between them, and some of 
them are known to trigger the activation of others, as well as interact with additional 
proteases to generate proteolytic cascades in certain systems.  
Of all MMPs, the interstitial collagenase, MMP-1, and stromelysin 1, or MMP-3, are the best 
characterized in the setting of synovitis. MMP-3 is able to degrade the most abundant 
extracellular components of the synovial tissue, including fibronectin and laminin, as well as 
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collagens I and III. In addition, it activates MMP-1, which not only shares some of MMP-3 
cleavage targets, but is also able to degrade collagen II, the principal component of articular 
cartilage. Plasma levels of both proteases have been found to be increased in patients with 
rheumatoid arthritis (Manicourt et al., 1995). Moreover, they correlated with disease activity, 
while intra-joint concentrations of the enzymes increased in parallel with the degree of joint 
inflammation (Ishiguro et al., 1996). Plasma levels of MMP-3 are currently regarded as a 
surrogate marker of severity, a fact that reflects its relevance as a mediator of joint 
destruction in rheumatoid arthritis. With immune-detection techniques, MMP-1 and -3 
show a patchy distribution throughout the inflamed synovial tissue. Both molecules are 
consistently found at CPJs, where a diffuse immune-reactivity has been described (Tetlow & 
Woolley, 1995). Their pattern of distribution has confirmed synovial fibroblasts as the major 
source of these molecules in the joint. 
Also of interest are the group of membrane-anchored (MT-) MMPs, which are bound to 
integrin chains, and, upon activation, digest pericellular matrix. Of this family, MT1-MMP 
(also MMP-14), which is over-expressed in rheumatoid synovial fibroblasts, is thought to 
confer to these cells some of their invasive potential (Yamanaka et al., 2000). In this regard, 
experiments carried out in the SCID mouse co-implantation model have shown the 
participation of MMP-1 and MT1-MMP in the degradation of cartilage by rheumatoid 
synovial fibroblasts (Rutkauskaite et al., 2004; Rutkauskaite et al., 2005). Based on this 
evidence, the pathway of MMPs has been for a while a promising area of research for 
therapeutics, not only in rheumatoid arthritis but also in metastatic tumours. The members 
of the family of tissue inhibitor of metalloproteinases (TIMPs), which act as natural 
regulators of MMPs, appeared as ideal candidates to develop anti-invasive compounds. In 
the SCID mouse model, TIMP-1 and -3 over-expressing mutants were able to slow the 
invasive process (van der Laan et al., 2003). However, less convincing results have been 
drawn so far in therapeutic experimental approaches and clinical trials. 
In summary, it appears that synovial fibroblasts are the main effectors of destruction, a fact 
that could be considered natural. Fibroblasts are in charge of connective tissue remodelling, 
both under physiologic conditions and in disease. Production of proteases allows them to 
migrate through the matrix and restore the injured site in wound healing processes 
(Woessner, 1991). The same mechanisms take place during invasive processes. In this 
regard, rheumatoid synovial fibroblasts have been compared to tumour-associated stromal 
cells, which are non-neoplastic fibroblasts that contribute to metastatic growth by the 
production of MMPs (Hotary et al., 2003). Interestingly, the presence of MMPs at the 
synovial tissue is not related to the stage of the disease, and in fact the proteases can be 
abundant in early synovitis (Katrib et al., 2001). Therefore, fibroblast activation is not 
necessarily a consequence of longstanding disease, but could be one of the distinguishing 
processes between non-progressive disease and rheumatoid arthritis. 
To help understand why rheumatoid and not other synovial fibroblasts turn invasive, a 
revealing study put in relationship the mRNA expression levels of MMPs with local 
hypoxia. Not only hypoxic cultures resulted in an increase in MMP-1 and MMP-3 
transcripts, but also HIF-1 siRNA transfects yielded 50% lower mRNA levels of MMP-3 
(Ahn et al., 2008).  
Pulling the thread of research coming from invasive neoplasms and stromal cells, additional 
synovial fibroblast-dependent proteases were discovered at CPJs, showing potent in vitro 
capacity to destroy bone and cartilage. One of these molecules, that heralds the aggressive 
behaviour of tumours, is the urokinase type plasmin activator (uPA) (Duffy & Duggan, 
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2004). While uPA is able to degrade the extracellular matrix, it also activates MMPs and 
proteoglycanases through the cleavage of their precursors. Several studies have shown that 
uPA is over-expressed in joints from patients with rheumatoid arthritis, in correlation with 
disease severity (van der Laan et al., 2000). In spite of this role, uPA could be a double-
edged therapeutic sword in rheumatoid arthritis, due to its activity in extra-vascular 
fibrinolysis, as we discuss in the next section. Interesting evidence was drawn in mice with 
antigen-induced arthritis, since uPA-deficient animals depicted a more severe phenotype as 
compared to wild type littermates (Busso et al., 1998). From subsequent studies, it can be 
concluded that aggressive features mediated by uPA are linked to its cell attachment 
activity, through the binding of its high affinity receptor, uPAR. New released work has 
found that the uPA-uPAR pair is a mediator of invasiveness in the SCID mouse co-
implantation model (Serratì et al., 2011). In turn, uPAR is part of a larger complex, the 
urokinase plasminogen activating system (uPAS), formed by its assembly with 4 serin 
protease inhibitors at the cell surface. Triggering of uPAS is associated to proliferation, 
adhesion, migration and neoangiogenesis in tumours. These findings point to the complex 
as a better therapeutic target than the protease itself (Ulisse et al., 2009). 
1.3 The role of fibrin in rheumatoid arthritis 
1.3.1 Haemostasis activation overflows the fibrinolytic capacity in the joints with 
rheumatoid arthritis 
Since the extra-vascular activation of haemostasis is a characteristic feature of inflammation, 
fibrin deposition in the inflamed synovial tissue is considered a non-specific event. During 
inflammation, the exudation of plasma into joints can result in coagulation factors achieving 
high concentrations at the synovial effusion. In fact, joints affected with osteoarthritis, 
infections, and trauma, often show fibrin deposits, albeit not as widespread as found in 
rheumatoid arthritis (Clemmensen et al., 1983). The striking abundance of fibrin in 
rheumatoid synovial tissues has been attributed to both an increased formation and a low 
clearance of the clots. As pointed out in different studies, rheumatoid arthritis flares 
provoke a status of extra-vascular thrombophilia, so that the influx of fibrinogen and its 
immobilization are high (Carmassi et al., 1996). Fibrin networks are thicker in patients with 
rheumatoid arthritis than in controls, and presumably more resistant to proteolysis as well 
(Kwasny-Krochin et al., 2010). This feature along with a reduced fibrinolytic activity can 
explain the accumulation of fibrin inside rheumatoid joints. Of the two regulatory systems 
that activate plasmin to degrade fibrin, the tissue plasminogen activator (tPA) is reduced in 
rheumatoid synovial tissues. Similarly, there is an increased production of the inhibitors of 
plasminogen activator, PAI-1 and PAI-2, which act by preventing fibrin dissolution through 
a constitutive pathway (Weinberg et al., 1991; Ronday, et al., 1996). 
Local activation of complement is an inflammation-dependent mechanism that can help to 
stabilize fibrin clots thereby decreasing the fibrinolytic potential of the joint. In particular, 
we explored some years ago the local production of the regulatory factor C4b-binding 
protein (C4BP). The protein C-S anticoagulatory system is a principal mechanism for 
preventing the uncontrolled activation of haemostasis. The beta chain of C4BP binds protein 
S with high affinity in an equimolecular fashion (Dahlbäck, 1989). Only free protein S is 
active and the free fraction depends on the availability of C4BP beta. Reduced levels of free 
protein S are associated with an increased risk of thrombotic events. Interestingly, we 
showed local production of C4BP beta by rheumatoid synovial fibroblasts, as well as its co-
localization with fibrin-rich areas at the synovial tissue (Sánchez-Pernaute et al., 2006). The 
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beta chain of C4BP has also been found in omen fibroblasts participating in the invasion and 
resorption of the corpus luteum, therefore indicating that besides its prothrombotic role, the 
molecule is important in fibroblast-dependent remodelling processes. 
In the light of these experimental data, a potential participation of fibrin in synovitis has 
been argued by different groups including ourselves (Busso & Hamilton, 2002; So et al., 
2003; Sánchez-Pernaute et al., 2003b), and several antithrombotic strategies have been tried, 
proving useful in attenuating the inflammatory process in experimental models of 
rheumatoid arthritis (Busso et al., 1998; Varisco et al., 2000). 
1.3.2 Fibrin as an autoantigen 
Fibrin is one of the major substrates for peptidyl deiminases (PAD) inside inflamed joints. 
These enzymes transform arginine residues into citrulline, and subsequently change the 
physical properties of the protein. This modification could alter binding sites of plasmin, 
making the polymer resistant to proteolytic degradation. Moreover, it can also turn the 
molecule antigenic (Schellekens et al., 1998). This fact was confirmed with the 
characterization of anti-citrullinated peptide antibodies (ACPA), since they were shown to 
target epitopes from fibrin in a specific association with rheumatoid arthritis (Masson-
Bessiere et al., 2001). Thus, fibrin can been considered a key mediator in the loss of immune 
tolerance in the disease. Since ACPA antibodies reach higher concentrations inside joints 
than at the periphery, deposition of fibrin in joints and exposure of its citrullinated form to 
immune-competent cells should be an early pathogenic event. On the other hand, ACPA can 
be found in pre-clinical stages in at least half of patients. To explain this contradiction, it has 
been suggested that the immune system is primed for citrullinated epitopes outside joints, 
for example in the lung or the oral cavity, with arthritis coming on a second wave (Quirke et 
al, 2011). We propose a different mechanism. According to recent studies, synovitis can 
remain asymptomatic during the first stages of the disease. A first mild flare of arthritis 
could, therefore, be the event during which citrullinated fibrinopeptides are generated 
inside joints and presented to the central immune system (van de Sande et al., 2011).  
1.3.3 Fibrin as a scaffold 
We focused our studies on “a non-immune” participation of fibrin in the development of 
synovitis. Since fibrin networks provide binding sites for the migration of cells, in this way 
facilitating wound healing, we proposed that the synovial tissue might grow through the 
engulfing of fibrin deposits at the lining surface. In a time-dependent approach, we studied 
events taking place from the first stages of the disease in antigen induced arthritis, and were 
able to describe the transition from acute inflammation, to deposition of fibrin clots, and 
subsequent synovitis-like tissue modifications taking place at fibrin-synovium interfaces 
(Sánchez Pernaute et al., 2003a). We then proposed that the binding of the free-surface of the 
lining cells would alter their polarity, thereby changing their resting phenotype into a 
migrating one, a mechanism that would contribute to invasiveness. 
1.3.3.1 Immobilization of fibrin affects cell binding 
Soluble fibrinogen turns into solid fibrin through the release of fibrinopeptides A and B, 
with the rest of its alpha and beta chains remaining mostly unchanged. Therefore, most cell 
binding sites are shared by the two macromolecules. But it is in our opinion the insolubility 
of fibrin which accounts for an invasive response of synovial fibroblasts in rheumatoid 
arthritis. Experiments carried out in macrophages demonstrated that the binding affinity of 
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cells increases with fibrinogen transformation into fibrin (Shainoff et al., 1990). Considering 
that blood cells express different alpha beta integrin chains that could bind circulating 
fibrinogen, the affinity of the soluble molecule needs to be low. In this regard, the shear 
forces elicited by fibrin networks may have an influence in the avidity towards cell 
receptors. This mechanism has been recently found to account for activation of colon 
tumour cells upon engagement of fibrin by the hyaluronate receptor, CD44 (Alves et a., 
2009). 
The cell binding activity of fibrin networks is further enriched by its cross-linking with 
different matrix proteins, including collagens, proteoglycans or fibronectin, which also bear 
a variety of cell binding sites. 
Yet to be understood, is why rheumatoid but not non-rheumatoid hosts develop an invasive 
response to fibrin clots inside joints. It could be simply a matter of magnitude, as we 
discussed several years ago (Sanchez-Pernaute et al, 2003b). It could also rely on intrinsic 
features of rheumatoid synovial fibroblasts, that up to date have not been found. 
Alternatively, it is attractive to speculate that resistance of the clots to plasmin proteolysis in 
rheumatoid joints makes local macrophages and fibroblasts secrete additional proteases that 
degrade fibrin through a non-constitutive pathway (Bini et al., 1999). Between these 
potential fibrin-degrading proteases stands MMP-3, which is also one of the major 
mediators of joint destruction. In this way, the active process of digestion of the insoluble 
macromolecule could be regarded as a favourable environment for the destruction of 
structures nearby. 
1.3.4 A potential role of fibrin in the architecture of synovitis 
The early works focused on the histopathology of rheumatoid arthritis, described a gradient 
in fibrin deposition from more abundant and solid-like at the surface, to patchy and 
reticular in inner areas (Andersen & Gormsen, 1970). Working with specimens from patients 
undergoing joint replacement surgery we described that fibrin-rich areas of the synovium 
were organized differently than non-fibrinous regions (Sánchez-Pernaute et al., 2006). With 
immune-detection techniques we found that both cells and extracellular matrix elements 
had a differential distribution in fibrinous and non-fibrinous areas, and there were transition 
zones between them (Figure 1). In this regard, matrix deposition and fibroblast-like synovial 
cells, as well as vessels, increased in density in fibrin-rich areas, up to an interface with 
solid-like fibrin deposits at superficial areas, where cells were scant and there were no 
vessels. Macrophages were clustered in the vicinity of fibrin deposits, although they were 
also abundant in non-fibrinous regions; but lymphoid aggregates clearly stayed apart 
(unpublished observations). This particular organization has led us to focus on the 
interaction between fibrin and synovial fibroblasts aiming to find mechanisms of 
invasiveness induced by fibrin in these cells. 
Studies conducted in synovial specimens are frequently based on small biopsies. These 
explants constitute a fine way to reflect events taking place in the whole synovial tissue, in 
particular as regards cell activation and the participation of subtypes of infiltrating leukocytes 
(Smith et al., 2006). Elegant studies have proved that the pathology of the synovial tissue from 
biopsies can be employed to measure response to therapy and even unveil specific molecular 
predictive markers. However, this kind of study rarely describes the features of fibrin-rich 
areas, probably because in these regions the architecture of the tissue is distorted and difficult 
to read (as illustrated in figure 1). We believe that these areas are routinely discarded and thus 
critical components of the synovial pathology might be underestimated. 
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Fig. 1. Stratification of synovitis in relationship to fibrin deposits in a representative 
rheumatoid synovial tissue 
Low-magnification microphotographs of a representative rheumatoid synovial tissue with 
an overlying fibrin deposit. Left column shows staining of the different tissue regions with 
haematoxylin-eosin. Middle column shows cell distribution with anti  actin antibodies. On 
the right side, immune-localization of macrophages with anti CD68 antibodies is shown. 
2. Fibrin contributes to the production of MMP-1 and MMP-3 by rheumatoid 
synovial fibroblasts 
In order to test whether deposition of fibrin might trigger the production of MMPs, we 
investigated the presence of fibrin in synovial tissues from patients with rheumatoid 
arthritis. We observed a similar pattern of distribution to those of MMP-1 and -3. These 
findings led us to explore in vitro whether fibrin could activate the production of MMPs by 
rheumatoid synovial fibroblasts. In these studies, which we next describe, we introduced an 
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in vitro system that attempts to reproduce the interaction between fibrin and fibroblasts that 
takes place inside the joint. This model of cell stimulation had originally been developed to 
study leukocyte migration through vessel walls and is known as in situ fibrin 
polymerization (Qi & Kreutzer, 1995). In contrast to other types of cultures involving cells 
and matrix proteins, this approach conserves the shear forces of freshly clotted fibrin 
networks and exposes cells to the deposits by their apical surface. 
2.1 Experimental methods 
2.1.1 Obtention and handling of samples 
Synovial tissues were obtained during joint replacement surgery from 8 patients with 
rheumatoid arthritis according to the American College of Rheumatology criteria (Arnett et 
al., 1988). For histologic studies, the synovial membrane was immediately fixed in 
formaldehyde, dehydrated in ethanol and embedded in paraffin. When tissues included 
bone edges, they were decalcified by a 48 hour incubation in formic acid. For in vitro 
studies, cells were isolated by disruption with 1.5 mg/ml dispase II at 37ºC for 1 hour in 
agitation, and cultured in 10% fetal calf serum (FCS) enriched Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 2 mM L-glutamine, 50 UI/ml penicillin-streptomycin, 
0.2% amphotericin B, and 10 mM HEPES. 
2.1.2 Immune-detection techniques 
We studied the distribution of fibrin, MMP-1 and MMP-3 with double labelling immune-
detection methods. Tissues were rehydrated, blocked with 6% bovine albumin and 3% 
serum of second antibody hosts, and incubated with the specific antibodies at 10 g/ml 
overnight, at 4ºC. Secondary antibodies were applied for 1 hour, at room temperature. As 
control, tissues were incubated with an isotype IgG from the species of primary antibodies. 
Development of fibrinogen immune-reactivity was done with peroxidase and Histogreen, 
using nuclear fast red for counterstaining. Diaminobenzidine was applied after a 
byotinilated secondary antibody to develop MMP-3, and counterstaining was done with 
hematoxylin. An alkaline phosphatase labelled antibody was employed to detect MMP-1, 
and nitroblue tetrazolium with 5-bromo 4-chloro 3-indolyl phosphate was used as substrate 
for development, plus nuclear fast red as counterstaining. Inhibition of endogenous 
peroxidase was done with 1% H2O2 methanol. Alkaline phosphatase activity was blocked 
with 5 mM levamisole.  
2.1.3 Fibrin-cell cultures 
Between passages 4th and 7th cells were grown to confluence at 37ºC in 5% CO2, starved from 
serum during 48 hours and exposed to in situ clotted fibrin. Chilled fibrinogen was mixed in 
0.5% foetal calf serum enriched DMEM at 1 mg/ml on ice, and 0.75 UI/ml thrombin was 
added. The mixture was immediately spread on top of the cell monolayers and the cultures 
were transferred to the incubator to allow formation of fibrin clots. 
2.1.4 Gene expression studies 
Four different cell cultures were employed. Cells were incubated with fibrin or medium 
alone for 12 hours. At the end of the incubation period, the clots and supernatants were 
removed, cells were washed and total RNA was isolated. Following retrotranscription, gene 
expression studies were done with quantitative PCR (qPCR) using cDNA as templates and 
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TaqMan primer-probe reagents (MMPs) or SYBR Green techniques (urokinase). Results 
were analysed following the Ct method, using the expression of ribosomal 18s as house 
keeping gene and an untreated culture as reference. 
2.1.5 Immunoblot techniques 
Confluent cells were incubated with or without fibrin and protein levels of MMPs were 
measured at several time points. The protein levels of MMP-1 were determined in cells 
lysates as obtained with Laemmli’s solution. Supernatants and fibrin were mixed with 150 
mM NaCl, 10 mM Tris, pH 7.2, 0.1% sodium dodecyl sulphate, 1% Triton X-100, 1% 
sodium deoxycholate and 5 mM ethylenediamine tetraacetic actid, with 1 g/ml 
aprotinin, 1 g/ml leupeptin, 1 mM Na3VO4, and 1 mM phenylmethylsulfonylfluoride, at 
4ºC and homogenised. One hundred l of the homogenates were incubated with the anti 
MMP-3 antibody for 1 hour at 4ºC. Then, protein A/G plus-agarose immunoprecipitation 
reagent (20 l) was added, and samples were incubated overnight on a rocking platform 
at 4ºC. Finally, samples were washed and centrifuged to pellet beads with the complexed 
MMP-3, supernatants were discarded and precipitates were mixed in loading buffer. 
Protein extracts and immuno-precipitates were resolved in 10% SDS-polyacrylamide gel 
electrophoresis and transferred onto nitrocellulose filters. The filters were then blocked 
with 5% skimmed milk and 0.03% Tween and blotted overnight with the specific 
antibodies. Horseradish peroxidase-labelled secondary antibodies were applied for 1 
hour, at room temperature, and the binding was developed with enhanced chemi-
luminescence. Results were expressed as relative increase with regard to baseline. Beta-
tubulin levels were used as control of cell protein content, and the Coomassie blue 
staining method was used in supernatants. 
2.1.6 Statistics 
Data are expressed as median (range); comparison between conditions was done with the 
non-parametric Wilcoxon rank test, using SPSS software.  
2.1.7 Reagents and probes 
Mouse anti human MMP-1 and goat anti human MMP-3 (R&D systems, Basel, Switzerland), 
goat anti human Fibrinogen (Abcam, Cambridge, UK), donkey anti goat-HRP, goat anti 
mouse-HRP, rabbit anti goat biotinylated antibodies, 1:500 in IHC, 1:10000 in WB (Jackson 
ImmunoResearch, LaRoche, Switzerland), goat anti mouse-alkaline phosphatase antibodies 
1:40, Histogreen, nuclear fast red, DAB, peroxidase ABComplex (Dako, Zug, Switzerland), 
NBT-BCIP (Roche), Protein A/G Plus Agarose Immunoprecipitation Reagent (Santa Cruz 
Biotechnology Inc., CA), ECL chemoluminiscence (Amersham Pharmacia Biotech, Little 
Chalfont, UK) Fetal calf serum, DMEM, penicillin, streptomycin, HEPES, fungizone (Life 
Technologies, Basel, Switzerland), dispase (Roche, Reinach, Switzerland), fibrinogen 
(American Diagnostica inc., Stamford, CT), mouse anti human tubulin, thrombin (Sigma 
Aldrich, Buchs, Switzerland) MiniRNeasy spin column purification kit, RNase-free DNase 
set (Qiagen, Basel, Switzerland), SYBR green master mix, ABI Prism 7500 Sequence Detector 
(Applied Biosystems, Rotkreuz, Switzerland). Primer pairs and probes: MMP 1: 5’-
tgtggaccatgccattgaga-3’ (fwd), 5’-tctgcttgaccctcagagacc-3’ (rev), FAM5’-
ccaactctggagtaatgtcacacctctgacattcacc-3’TAMRA (probe); MMP 3: 5’-gggccatcagaggaaatgag-
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3’ (fwd), 5’-cacggttggagggaaaccta-3’ (rev), FAM5’-agctggatacccaagaggcatccacac-3’TAMRA 
(probe); MMP 9: 5’-ggccactactgtgcctttgag-3’ (fwd), 5’-gatggcgtcgaagatgttcac-3’ (rev), FAM5’-
ttgcaggcatcgtccaccgg-3’TAMRA (probe); MMP 13: 5’-tcctacaaatctcgcgggaat-3’ (fwd), 
gcatttctcggagcctctca-3’ (rev), FAM5’-catggagcttgctgcattctccttcag-3’TAMRA (probe); MMP 14: 
5’-tggaggagacacccactttga-3’ (fwd), 5’-gccaccaggaagatgtcatttc-3’ (rev), FAM5’-
cctgacagtccaaggctcggcaga-3’TAMRA (probe); urokinase: 5’-tgtcagcagccccactactac-3’ (fwd), 
5’-cacagcattttggtggtgac-3’ (rev). 
2.2 Results 
2.2.1 Fibrin and MMPs co-localized in the synovial tissues from patients with 
rheumatoid arthritis 
We studied the distribution of fibrin(ogen) in synovial tissues from 8 patients with 
rheumatoid arthritis. Three of them included areas of invasion into cartilage and bone. The 
binding was strong and abundant in all samples, showing either an amorphous or a 
reticular pattern, as has been described (Andersen & Gormsen, 1970; Clemmensen et al., 
1983). Fibrin predominated in the vicinity of the lining layer. Solid-looking deposits were 
mostly acellular, while more organized material was found in interstitial areas, with cells 
inside also capturing the antibody. Fibrin immune-reactivity was strong at areas of interface 
with bone and cartilage. 
Next, we studied the distribution of MMP-1 and MMP-3 in serial cuts of the same tissues, 
alone and in combination with fibrin, using double-staining methods. Immune-reactivity to 
both MMPs was high in the rheumatoid synovial tissues. Interestingly, MMP-1 
predominated inside cells, and MMP-3 was mostly secreted. The binding of both antibodies 
was high at erosive fronts. 
In double-staining studies, interstitial immune-reactivity to both MMP-1 and MMP-3 was 
associated with fibrin deposits. Furthermore, both proteases co-localized with fibrin at the 
invasive fronts. Fibroblast-like cells in fibrin-rich areas depicted a strong immune-reactivity 
to MMP-1 and MMP-3. These findings indicated that fibrin-rich areas were at the same time 
active sites of protease production. 
2.2.2 Gene expression of proteases in rheumatoid synovial fibroblasts exposed to 
fibrin clots 
In view of these observations, we carried out in vitro studies to look into a possible effect of 
fibrin on the production of proteases by rheumatoid synovial fibroblasts. 
Thus, we studied five members of the MMP family that are prominent effectors of cartilage 
and bone destruction in rheumatoid arthritis. This revealed that exposure to in situ clotted 
fibrin resulted in the up-regulation of the gene expression of MMP-1, MMP-3, and MMP-9 to a 
variable extent in all cell cultures (Figure 3). The mRNA levels of MMP-1 were 26-fold 
increased (range: 1,5 to 71; p < 0.07), and those of MMP-3 were 27-fold increased (range: 2 to 
126; p < 0.07). MMP-9 gene expression was increased 7-fold the presence of fibrin (range: 3 to 
39; p < 0.07), while no differences were found in the gene expression of MMP-13 and MMP-14. 
Additionally, we studied urokinase gene expression, since it is the constitutive fibrin-
degrading molecule, and a potential mediator of tissue injury in rheumatoid synovial 
tissues. In our conditions, fibrin did not elicit any changes in urokinase mRNA levels 
compared to baseline. 
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Fig. 2. Immune-staining of fibrin and MMPs in the rheumatoid synovial tissues 
Left column shows a low-magnification view of a fibrin-rich area of the synovial tissue, with 
the different staining techniques. Middle column shows the intimal layer of a fibrin-rich area 
in detail. Right column depicts the staining of the molecules at areas of invasion into bone and 
cartilage. Fibrin is shown in green (with red counterstaining), MMP-3 is shown in brown (and 
counterstained in blue), and MMP-1 is shown in blue (with red counterstaining). 
2.2.3 Fibrin increased the production of MMP-1 by rheumatoid synovial fibroblasts 
Six different cell cultures were employed in immunoblot experiments. In all cases, treatment 
with fibrin increased MMP-1 production. In our conditions, both the proenzime and the 
active form of MMP-1 increased between 18 h and 24 h in rheumatoid synovial fibroblasts 
treated with fibrin (Figure 3). At 24 h, the active enzyme increased to 4-fold as compared to 
untreated cells (range: 1,5 to 6; p < 0.03). On the other hand, we could not detect MMP-3 in 
cell lysates, but it was abundantly found in supernatants from cell cultures. Upon 
stimulation with fibrin, baseline levels of MMP-3 in supernatants were found increased only 
in half of the cell lines tested (ns) (Figure 3).  
2.3 Discussion and future research 
Our studies illustrate how deposition of fibrin can contribute to the invasive process in 
rheumatoid arthritis. Previous works had described the distribution of MMP-1 and MMP-3 
in the rheumatoid synovial tissue. In the same way, fibrin distribution in rheumatoid joints 
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was well known. A novel finding is that all three followed a similar pattern of distribution. 
We could also confirm their abundance at CPJs, although we cannot draw conclusions as 
regards the impact of these finding in the erosive tendency. 
Our studies suggest that fibrin triggers the transcription of several MMPs and the 
production of MMP-1. However, the study of MMPs is complex. These molecules are 
secreted in the form of zymogens, and need in situ activation through the cleavage of an N-
terminus peptide. This post-translational modification probably constitutes a major check-
point for the regulation of MMPs. Additionally, to find out what the global matrix turn-over 
could be, it would have been desirable to assess levels of TIMPs. TIMPs are the natural 
regulators of MMPs, an effect carried out through an equimolecular binding and 
inactivation. Both chondrocytes and synovial fibroblasts can produce TIMPs. In this regard, 
the balance between TIMPs and MMPs is decisive for the outcome (Martel-Pelletier et al., 
1994). Functional studies, such as substrate-based zymography, are usually performed to 
demonstrate active proteolysis.  
 
 
Fig. 3. Expression of MMPs in rheumatoid synovial fibroblasts exposed to fibrin 
Graphs on the left show changes in baseline level expression of the mentioned genes 
(median  SEM), in Ct values using 18s as house keeping gene (the lower Ct values, the 
higher gene levels are). On the right, representative immunoblots from different 
experiments are shown. Detection of MMP-1 was done in cell lysates and MMP-3 was 
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studied in the extracellular fraction. Both antibodies detected both the zymogen (upper 
band) and the active protease (lower band). 
Nevetheless, it was interesting to find that three MMPs previously correlated to the invasive 
potential of rheumatoid synovial fibroblasts, were up-regulated by fibrin at the mRNA level 
(Tolboom et al., 2002). Due to its insolubility, fibrin might be degraded in a non-constitutive 
way by MMP-3 secreted by surrounding cells (Bini et al., 1999). On the balance of the 
evidence, we believe that fibrin-rich regions should not be considered a result of long-
standing inflammation, but a site for active destruction. 
In agreement with previous studies, most of the synovial fibroblast cultures that we 
employed in our studies did not constitutively express MMP-13 as assessed with qPCR 
techniques, and only in some was it induced after exposure to fibrin (Moore et al., 2000). In 
the production of this, as well as the other proteases tested, there seemed to be a high 
variability between patients. In fact, our studies suggested the existence of two subsets 
according to their response to fibrin. Approximately half of the cultures strongly reacted 
with the up-regulation of MMPs, while the other half showed mild or absent response. We 
believe that this is another example of the heterogeneous character of rheumatoid arthritis. 
Although there was no regulation of MT1-MMP at the mRNA level by fibrin, an interesting 
finding drawn by our experiments was the high expression of MT1-MMP by unstimulated 
rheumatoid synovial cells, pointing to the prominent role of the protease in the activity of 
synovial fibroblasts as already suggested (Miller et al., 2009). 
In summary, using a novel culture system for the study of fibrin interaction with synovial 
cells, we could show induction of proteases putatively associated to invasiveness, that were 
further localized at fibrin-rich areas in the synovial tissues.  
3. Conclusion 
In this chapter, we give an overview of the role of fibrin in the pathogenesis of synovitis. In 
doing so, we have neither solved the paradigm about what starts first nor discovered what 
triggers the invasive behaviour of rheumatoid synovial fibroblasts. Instead we provide some 
lines of thinking supporting the “inside – out pathway” as it has recently been named 
(Schett & Firestein, 2010).  
The “fibrin pathway” has been little explored in rheumatoid arthritis therapeutics. The 
balance between clotting and dissolution of fibrin is a candidate process to target that could 
help to retard joint destruction.  
4. Acknowledgements 
We thank Conchita Rábago Foundation (FCR) and the Foundation of the Spanish Society for 
Rheumatology (FER) for their financial support. 
5. References 
Ahn, J.K.; Koh, E.M., Cha, H.S., Lee, Y.S., Kim, J., Bae, E.K. & Ahn, K.S. (2008). Role of 
hypoxia-inducible factor-1alpha in hypoxia-induced expression of IL-8, MMP-1 and 
MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford), Vol.47, 
No.6, pp. 834-839, ISSN: 1462-0324 
www.intechopen.com
 
Innate Mechanisms of Synovitis – Fibrin Deposits Contribute to Invasion 
 
125 
Alves, C.S.; Yakovlev, S., Medved, L. & Konstantopoulos, K. (2009). Biomolecular 
characterization of CD44-fibrin(ogen) binding: distinct molecular requirements 
mediate binding of standard and variant isoforms of CD44 to immobilized 
fibrin(ogen). J Biol Chem, Vol.284, No.2, pp. 1177-1189, ISSN: 0021-9258 
Andersen, R.B. & Gormsen, J. (1970). Fibrinolytic and fibrin stabilizing activity of synovial 
membranes. Ann Rheum Dis, Vol.29, No.3, pp. 287-293, ISSN: 0003-4967 
Arend, W.P. (1997). The pathophysiology and treatment of rheumatoid arthritis. Arthritis 
Rheum, Vol.40, No.4, pp. 595-597, ISSN: 0004-3591 
Arnett, F.C.; Edworthy, S.M, Bloch, D.A., McShane. D,J., Fries, J.F., Cooper, N.S. et al. (1988). 
The American Rheumatism Association 1987 revised criteria for the classification of 
rheumatoid arthritis. Arthritis Rheum, Vol.31, No.3, pp. 315-324, ISSN: 0004-3591 
Benito, M.J.; Murphy, E., Murphy, E.P., van den Berg, W.B., FitzGerald, O. & Bresnihan, B. 
(2004). Increased synovial tissue NF-kappa B1 expression at sites adjacent to the 
cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum, Vol.50, No.6, pp. 
1781-1787, ISSN: 0004-3591 
Bini, A.; Wu, D., Schnuer, J. & Kudryk, B.J. (1999). Characterization of stromelysin 1 (MMP-
3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-
MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal 
sequences of late-stage digest fragments. Biochemistry,  Vol.38, No.42, pp. 13928-
13936, ISSN: 0006-2960 
Brennan, F.M.; Chantry, D., Jacksin, AM., Maini, R.N. & Feldmann, M. (1989). Cytokine 
production in culture by cells isolated from the synovial membrane. J Autoimmun, 
Vol.2 Suppl, pp. 177-186, ISSN: 0896-8411 
Brennan, F.M.; Chantry. D., Jackson, A., Maini, R. & Feldmann, M. (1989). Inhibitory effect 
of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid 
arthritis. Lancet, Vol.2, No.8657, pp. 244-247, ISSN: 0140-6736 
Busso, N.; Peclat, V., Van Ness, K., Kolodziesczyk, E., Degen, J., Bugge, T. & So, A. (1998). 
Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest, 
Vol.102, No.1, pp. 41–50, ISSN: 0021-9738 
Busso, N. & Hamilton, J.A. (2002). Extravascular coagulation and the plasminogen 
activator/plasmin system in rheumatoid arthritis. Arthritis Rheum, Vol.46, No.9, pp. 
2268-2279, ISSN:  
Carmassi, F.; de Negri, F., Morale, M., Song, K.Y. & Chung, S.I. (1996). Fibrin degradation in 
the synovial fluid of rheumatoid arthritis patients: a model for extravascular 
fibrinolysis. Semin Thromb Hemost, Vol.22, No. 6, pp. 489–496, ISSN: 0094-6176 
Clemmensen, I.; Holund, B. & Andersen, R.B. (1983). Fibrin and fibronectin in rheumatoid 
synovial membrane and rheumatoid synovial fluid. Arthritis Rheum, Vol.26, No.4, 
pp. 479-485, ISSN: 0004-3591 
Dahlbäck, B. (1986). Inhibition of protein Ca cofactor function of human and bovine protein 
S by C4b-binding protein. J Biol Chem, Vol.261, No.26, pp. 12022-12027, ISSN: 0021-
9258 
Distler, J.H.W.; Wenger, R.H., Gassmann, M., Kurowska, M., Hirth, A., Gay, S. & Distler, O. 
(2004). Physiologic responses to hypoxia and implications for hypoxia-inducible 
factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum, Vol.50, No.1, 
pp. 10-23, ISSN: 0004-3591 
www.intechopen.com
 
Rheumatoid Arthritis – Etiology, Consequences and Co-Morbidities 
 
126 
Duffy, M.J. & Duggan, C. (2004). The urokinase plasminogen activator system: a rich source 
of tumour markers for the individualised management of patients with cancer. Clin 
Biochem, Vol.37, No.7, pp. 541-548, ISSN: 0009-9120 
Firestein, G.S. & Zvaifler, N.J. (2002). How important are T cells in chronic rheumatoid 
synovitis? II. T cell-independent mechanisms from beginning to end. Arthritis 
Rheum, Vol.46, No.2, pp 298-308, ISSN: 0004-3591 
Franz, J.K.; Pap, T., Hummel, K.M., Nawrath, M., Aicher, W.K., Shigeyama, Y. et al. (2000). 
Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion 
in rheumatoid arthritis. Arthritis Rheum, Vol.43, No.3, pp. 599-607, ISSN: 0004-3591 
Haworth, C.; Brennan, F.M., Chantry, D., Turner, M., Maini, R.N. & Feldmann, M. (1991). 
Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid 
arthritis: regulation by tumor necrosis factor-alpha. Eur J Immunol, Vol.21, No.10, 
pp. 2575-2579, ISSN: 1521-4141 
Hotary, K.B.; Allen, E.D., Brooks, P.C., Datta, N.S., Long, M.W. & Weiss, S.J. (2003). 
Membrane type I matrix metalloproteinase usurps tumor growth control imposed 
by the three-dimensional extracellular matrix. Cell, Vol.114, No.1, pp. 33-45, ISSN: 
0092-8674 
Ishiguro, N.; Ito, T., Obata, K., Fujimoto, N. & Iwata, H. (1996). Determination of 
stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of 
metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from 
patients with rheumatoid arthritis. J Rheumatol, Vol.23, No.9, pp. 1599-1604, ISSN: 
0315-162X 
Jüngel, A.; Baresova, V., Ospelt, C., Simmen, B.R., Michel, B.A., Gay, R.E. et al. (2006). 
Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-
induced apoptosis. Ann Rheum Dis, Vol.65, No.7, pp. 910–912, ISSN: 0003-4967 
Jüngel, A.; Ospelt, C., Lesch, M., Thiel, M., Sunyer, T., Schorr, O. et al. (2010). Effect of the 
oral application of a highly selective MMP-13 inhibitor in three different animal 
models of rheumatoid arthritis. Ann Rheum Dis, Vol.69, No.5, pp. 898-902, ISSN: 
0003-4967 
Kammouni, W.; Wong, K, Ma, G., Firestein, G.S., Gibson, S.B. & El-Gabalawy, H.S. (2007). 
Regulation of apoptosis in fibroblast-like synoviocytes by the hypoxia-induced Bcl-
2 family member Bcl-2/Adenovirus E1B 19-kd protein-intercting protein 3. Arthritis 
Rheum, Vol.56, No.9, pp. 2854-2863, ISSN: 0004-3591 
Kasperkovitz, P.V.; Timmer, T.C., Smeets, T.J., Verbeet, N.L., Tak, P.P., van Baarsen, L.G. et 
al. (2005). Fibroblast-like synoviocytes derived from patients with rheumatoid 
arthritis show the imprint of synovial tissue heterogeneity: evidence of a link 
between an increased myofibroblast-like phenotype and high-inflammation 
synovitis. Arthritis Rheum, Vol.52, No.2, pp. 430-441, ISSN: 0004-3591 
Katrib, A.; Tak, P.P., Bertouch, J.V., Cuello, C., McNeil, H.P., Smeets, T.J. et al. (2001). 
Expression of chemokines and matrix metalloproteinases in early rheumatoid 
arthritis. Rheumatology (Oxford), Vol.40, No.9, pp. 988-994, ISSN: 1462-0324 
Kim, K.W.; Cho, M.L., Lee, S.H., Oh, H.J., Kang, C.M., Ju, J.H. et al. (2007). Human 
rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating 




Innate Mechanisms of Synovitis – Fibrin Deposits Contribute to Invasion 
 
127 
Kwasny-Krochin, B.; Gluszko, P. & Undas, A. (2010). Unfavorably altered fibrin clot 
properties in patients with active rheumatoid arthritis. Thromb Res, Vol.126, 
No.1:e11-6, ISSN: 1879-2472 
Manicourt, D.H.; Fujimoto N., Obata, K. & Thornal E.J. (1995). Levels of circulating 
collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in 
patients with rheumatoid arthritis. Relationship to serum levels of antigenic 
keratan sulfate and systemic parameters of inflammation. Arthritis Rheum, Vol.38, 
No.8, pp. 1031-1039, ISSN: 0004-3591 
Martel-Pelletier, J.; McCollum, R., Fujimoto, N., Obata, K., Cloutier, J.M. & Pelletier- J.P. 
(1994). Excess of metalloproteases over tissue inhibitor of metalloprotease may 
contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lav 
Invest, Vol.70, No.6, pp. 807-815, ISSN: 0023-6837 
Masson-Bessière, C.; Sebbag, M., Girbal-Neuhauser, E., Nogueira, L., Vincent, C., Senshu, T. 
& Serre, G. (2001). The major synovial tiargets of the rheumatoid arthritis-specific 
antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of 
fibrin. J Immunol, Vol.166, No.6, pp. 4177-4184, ISSN: 0022-1767 
Moore, B.A.; Aznavoorian, S., Engler, J.A. & Windsor, L.J. (2000). Induction of collagenase-3 
(MMP-13) in rheumatoid synovial fibroblasts. Biochim Biophys Acta, Vol.1502, No.2, 
pp. 307-318, ISSN: 0006-3002 
Müller-Ladner, U.; Kriegsmann, J., Franklin, B.N., Matsumoto, S., Geiler, T., Gay, R.E. & 
Gay, S. (1996). Synovial fibroblasts of patients with rheumatoid arthritis attach to 
and invade normal human cartilage when engrafted into SCID mice. Am J Pathol, 
Vol.149, No.5, pp. 1607–1615, ISSN: 0002-9440 
Pap, T.; Shigeyama, Y., Kuchen, S., Fernihough, J.K., Simmen, B., Gay R.E. & et al. (2000). 
Differential expression pattern of membrane-type matrix metalloproteinases in 
rheumatoid arthritis. Arthritis Rheum, Vol.43, pp. 1226-1232, ISSN: 0004-3591 
Pap, T.; Nawrath, M., Heinrich, J., Bosse, M., Baier, A. & Hummel, K.M. (2004). Cooperation 
of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness 
of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum, Vol.50, No.9, pp. 
2794-2802, ISSN: 0004-3591 
Pap, T.; Meinecke, I., Müller-Ladner, U. & Gay, S. (2005). Are fibroblasts involved in joint 
destruction? Ann Rheum Dis, Vol.64, Suppl4, pp. iv52-54, ISSN: 0003-4967 
Qi, J. & Kreutzer, D.L. (1995). Fibrin activation of vascular endothelial cells. Induction of IL-8 
expression. J Immunol, Vol.155, No.2, pp. 867-876, ISSN: 0022-1767 
Quirke, A.M.; Fisher, B.A., Kinloch, A.J. & Venables, P.J. (2011). Citrullination of 
autoantigens: Upstream of TNF in the pathogenesis of rheumatoid arthritis. FEBS 
Lett, Jun 23, [Epub ahead of print], ISSN: 1873-3468 
Ronday, H.K.; Smits, H.H., Van Muijen, G.N., Pruszczynski, M.S., Dolhain, R.J. et al. (1996). 
Difference in expression of the plasminogen activation system in synovial tissue of 
patients with rheumatoid arthritis and osteoarthritis. Br J Rheumatol, Vol. 35, No.5, 
pp. 416-423, ISSN: 0263-7103 
Rutkauskaite, E., Zacharias, W., Schedel, J., Müller-Ladner, U., Mawrin, C., Seemayer, C.A., 
et al. (2004). Ribozymes that inhibit the production of matrix metalloproteinase 1 
reduce the invasiveness of rheumatoid arthritis synovial fibroblasts. Arthritis 
Rheum, Vol.50, 1448-1456, ISSN: 0004-3591 
www.intechopen.com
 
Rheumatoid Arthritis – Etiology, Consequences and Co-Morbidities 
 
128 
Rutkauskaite, E.; Volkmer, D., Shigeyama, Y., Schedel, J., Pap, G., Müller-Ladner, U. et al. 
(2005). Retroviral gene transfer of an antisense construct against membrane type 1 
matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial 
fibroblasts. Arthritis Rheum, Vol.52, No.7, pp. 2010-2014, ISSN: 0004-3591 
Sánchez-Pernaute, O.; López-Armada, M.J., Calvo, E., Díez-Ortego, I., Largo, R., Egido, J. & 
Herrero-Beaumont, G. (2003). Fibrin generated in the synovial fluid activates 
intimal cells from their apical surface: a sequential morpholocial study in antigen-
induced arthritis. Rheumatology (Oxford), Vol.42, No.1, pp. 19-25, ISSN: 1462-0324 
Sánchez-Pernaute, O.; Largo, R., Calvo, E., Alvarez-Soria, M.A., Egido, J. & Herrero-
Beaumont, G. (2003). A fibrin based model for rheumatoid synovitis. Ann Rheum 
Dis, Vol.62, No.12, pp. 1135-1138, ISSN: 0003-4967 
Sánchez-Pernaute, O.; Esparza-Gordillo, J., Largo, R., Calvo, E., Alvarez-Soria, M.A., 
Marcos, M.E. et al. (2006). Expression of the peptide C4b-binding protein beta in the 
arthritic joint. Ann Rheum Dis, Vol.65, No.10, pp. 1279-1285, ISSN: 0003-4967 
Schedel, J.; Gay, R.E., Kuenzler, P., Seemayer, C., Simmen, B., Michel, B.A. & Gay, S. (2002). 
FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage 
and bone erosion in rheumatoid arthritis. Arthritis Rheum, Vol.46, No.6, pp. 1512-
1518, ISSN: 0004-3591 
Schellekens, G.A.; de Jong, B.A.W., van den Hoogen, F.H.J., van de Putte, L.B.A. & van 
Venrooij, W.J. (1998). Citrulline is an essential constituent of antigenic determinants 
recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest, Vol.101, 
No.1, pp. 273-281, ISSN: 0021-9738 
Schett, G. & Firestein, G.S. (2010). Mr Outside and Mr Inside: classic and alternative views 
on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis, Vol.69, No.5, pp. 787-
789, ISSN: 0003-4967 
Serratì, S.; Margheri, F., Chillà, A., Neumann, E., Müller-Ladner, U., Benucci, M. et al. (2011). 
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse 
model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial 
fibroblasts. Arthritis Rheum, May 5, doi: 10.1002/art.30439, ISSN: 1529-0131 
Shainoff, J.R.; Stearns, D.J., DiBello, P.M. & Hishikawa-Itoh, Y. (1990). Characterization of a 
mode of specific binding of fibrin monomer thorugh ist amino-terminal domain by 
macrophages and macrophage cell-lines. Thromb Haemost, Vol.63, No.2, pp. 193-203, 
ISSN: 0340-6245 
Smeets, T.J.; Kraan, M.C., Galjaard, S., Youssef, P.P., Smith, M.D. & Tak, P.P. (2001). Analysis 
of the cell infiltrat and expression of matrix metalloproteinases and granzyme B in 
paired synovial biopsy specimens from the cartilage-pannus junction in patients 
with RA. Ann Rheum Dis, Vol.60, pp. 561-565, ISSN: 0003-4967 
Smith, M.D.; Baeten, D., Ulfgren, A.K., McInnes, I.B., Fitzgerald, O., Bresnihan, B. et al. 
(2006). Standarisation of synovial tissue infiltrate analysis: how far have we come? 
How muc further do we need to go? Ann Rheum Dis, Vol.65, No.1, pp. 93-100, ISSN: 
0003-4967 
So, A.K.; Varisco, P.A., Kemkes-Matthes, B., Herkenne-Morard, C., Chobaz-Péclat, V., 
Gerster, J.C. & Busso, N. (2003). Arthritis is linked to local and systemic activation 
of coagulation and fibrinolysis pathways. J Thromb Haemost, Vol.1, No.12, pp. 2510-
2515, ISSN: 1538-7933 
www.intechopen.com
 
Innate Mechanisms of Synovitis – Fibrin Deposits Contribute to Invasion 
 
129 
Stevens, C.R.; Blake, D.R., Merry, P., Revell, P.A. & Levick, J.R. (1991). A comparative study 
by morphometry of the microvasculature in normal and rheumatoid synovium. 
Arthritis Rheum, Vol.34, No.12, pp. 1508-1513, ISSN: 0004-3591 
Takami, N.; Osawa, K., Miura, Y., Komai, K., Taniguchi, M., Shiraishi, M. et al. (2006). 
Hypermethylated promoter region of DR3, the death receptor 3 gene, in 
rheumatoid arthritis synovial cells. Arthritis Rheum, Vol.54, No.3, pp. 779–787, 
ISSN: 0004-3591 
Tarner, I.H.; Härle, P., Müller-Ladner, U., Gay, R.E. & Gay, S. (2005). The different stages of 
synovitis: acute vs chronic, eary vs late and non-erosive vs erosive. Best Pract Res 
Clin Rheumatol, Vol.19, No.1 pp. 19-35, ISSN: 1521-6942 
Tetlow, L.C. & Woolley, D.E. (1995). Mast cells, cytokines, and metalloproteinases at the 
rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis, Vol.54, No.11, 
pp. 896-903, ISSN: 0003-4967 
Tolboom, T.C.; Pieterman, E., van der Laan, W.H., Toes, R.E., Huidekoper, A.L., Nelissen, 
R.G. et al. (2002). Invasive properties of fibroblast-like synoviocytes: correlation 
with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann 
Rheum Dis, Vol.61, No.11, pp. 975-980, ISSN: 0003-4967 
Ulisse, S.; Baldini, E., Sorrenti, S. & D'Armiento, M. (2009). The urokinase plasminogen 
activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets, Vol.9, 
No.1, pp. 32-71, ISSN: 1568-0096 
van de Sande, M.G.; de Hair, M.J., van der Leij, C., Klarenbeek, P.L., Bos, W.H., Smith, M.D. 
et al. (2011). Ann Rheum Dis, Vol.70, No.5, pp. 77-777, ISSN: 0003-4967 
van der Laan, W.H.; Pap, T., Ronday, H.K., Grimbergen, J.M., Huisman, L.G., TeKoppele, 
J.M. et al. (2000). Cartilage degradation and invasion by rheumatoid synovial 
fibrobalsts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor. 
Arthritis Rheum, Vol.43, No.8, pp. 1710-1718, ISSN: 0004-3591 
van der Laan, W.H.; Quax, P.H., Seemayer, C.A., Huisman, L.G., Pieterman, E.J., 
Grimbergen, J.M. et al. (2003). Cartilage degradation and invasion by rheumatoid 
synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther, 
Vol.10, No.3, pp. 234-242, ISSN: 0969-7128 
Varisco, P. A.; Péclat, V., van Ness, K., Bischof-Delaloye, A., So, A. & Busso, N. (2000). Effect 
of thrombin inhibition on synovial inflammation in antigen induced arthritis. Ann 
Rheum Dis, Vol.59, No.10, pp. 781-787, ISSN: 0003-4967 
Weinberg, J.B.; Pippen, A.M. & Greenberg, C.S. (1991). Extravascular fibrin formation and 
dissolution in synovial tissues of patients with osteoarthritis and rheumatoid 
arthritis. Arthritis Rheum, Vol.34, No.8, pp. 996-1005, ISSN: 0004-3591 
Wernicke, D.; Schulze-Westhoff, C., Bräuer, R., Petrow, P., Zacher, J., Gay, S. & Gromnica-
Ihle, E. (2002). Stimulation of collagenase 3 expression in synovial fibroblasts of 
patients with rheumatoid arthritis by contact with a three.dimensional collagen 
matrix or with normal cartilage when coimplanted in NOD/SCID mice. Arthritis 
Rheum, Vol.46, No.1, pp. 64-74, ISSN: 0004-3591 
Wunrau, C.; Schnaeker, E.M., Freyth, K., Pundt, N., Wendholt, D., Neugebauer, K. & et al. 
(2009). Arthritis Rheum, Vol.60, No.9, pp. 2606-2611, ISSN: 0004-3591 
Woessner, J.F.Jr. (1991). Matrix metalloproteinases and their inhibitors in connective tissue 
remodeling. FASEB J, Vol.5, No.8, pp. 2145-2154, ISSN: 0892-6638 
www.intechopen.com
 
Rheumatoid Arthritis – Etiology, Consequences and Co-Morbidities 
 
130 
Yamanaka, H.; Makino, K., Takizawa, H., Fujimoto, N., Moriya, H. et al. (2000). Expression 
and tissue localization of membrane-types 1, 2, and 3 matrix metralloproteinases in 
rheumatoid synovium. Lab Invest, Vol.80, No.5, pp. 677-687, ISSN: 0023-6837 
Yoshihara, Y.; Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa, K. & Okada, 
Y. (2000). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in 
synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann 
Rheum Dis, Vol.59, No.6, pp. 455-461, ISSN: 0003-4967 
www.intechopen.com
Rheumatoid Arthritis - Etiology, Consequences and Co-Morbidities
Edited by Dr. Andrew Lemmey
ISBN 978-953-307-847-2
Hard cover, 304 pages
Publisher InTech
Published online 11, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The purpose of this book is to provide up-to-date, interesting, and thought-provoking perspectives on various
aspects of research into current and potential treatments for rheumatoid arthritis (RA). This book features 16
chapters, with contributions from numerous countries (e.g. UK, USA, Japan, Sweden, Spain, Ireland, Poland,
Norway), including chapters from internationally recognized leaders in rheumatology research. It is anticipated
that Rheumatoid Arthritis - Etiology, Consequences and Co-Morbidities will provide both a useful reference and
source of potential areas of investigation for research scientists working in the field of RA and other
inflammatory arthropathies.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Olga Sa ́nchez-Pernaute, Antonio Gabucio, Astrid Ju ̈ngel, Michel Neidhart, María Comazzi, Gabriel Herrero-
Beaumont, Renate E. Gay and Steffen Gay (2012). Innate Mechanisms of Synovitis – Fibrin Deposits
Contribute to Invasion, Rheumatoid Arthritis - Etiology, Consequences and Co-Morbidities, Dr. Andrew
Lemmey (Ed.), ISBN: 978-953-307-847-2, InTech, Available from:
http://www.intechopen.com/books/rheumatoid-arthritis-etiology-consequences-and-co-morbidities/innate-
mechanisms-of-synovitis-fibrin-deposits-contribute-to-invasion
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
